actions

What's new on the Web

• 18 June – Trans-Pacific Partnership undermines health system
• 18 June – Trans-Pacific Partnership undermines health system
• 18 June – The Supreme Court Reveals its Ignorance of Genetics
• 18 June – The Supreme Court Reveals its Ignorance of Genetics
• 18 June – DIPP to send proposal to PMO on review of pharma FDI policy
• 18 June – DIPP to send proposal to PMO on review of pharma FDI policy
• 14 June – SUPREME COURT INVALIDATES PATENTS ON BREAST AND OVARIAN CANCER GENES
• 14 June – SUPREME COURT INVALIDATES PATENTS ON BREAST AND OVARIAN CANCER GENES
• 14 June – ACLU Statement:Supreme Court Invalidates Patents on Breast and Ovarian Cancer Genes
• 14 June – ACLU Statement:Supreme Court Invalidates Patents on Breast and Ovarian Cancer Genes
• 14 June – Justices Strike Down Gene Patents
• 14 June – Justices Strike Down Gene Patents
• 14 June – Why can’t India and the EU sign an FTA?
• 14 June – Why can’t India and the EU sign an FTA?
• 13 June – EU Welcomes TRIPS Extension for LDCs
• 13 June – EU Welcomes TRIPS Extension for LDCs
• 13 June – MSF responds to TRIPS exclusion extension for least-developed countries
• 13 June – MSF responds to TRIPS exclusion extension for least-developed countries
• 13 June – TWN Info Service on WTO and Trade Issues (Jun13/05)
• 13 June – TWN Info Service on WTO and Trade Issues (Jun13/05)
• 13 June – Impact of evergreening on Swiss Healthcare Spending
• 13 June – Impact of evergreening on Swiss Healthcare Spending
• 13 June – Productivity Commission advocates change to compulsory licensing of patents
• 13 June – Productivity Commission advocates change to compulsory licensing of patents
• 13 June – Sun Pharma takes Novartis to US Court, seeks permission to market Glivec in US
• 13 June – Sun Pharma takes Novartis to US Court, seeks permission to market Glivec in US
• 13 June – EU to fine Ranbaxy, others for blocking generic drugs
• 13 June – EU to fine Ranbaxy, others for blocking generic drugs
• 13 June – WHO Director-General addresses health promotion conference
• 12 June – Guest column : Is Indian Pharma’s spectacular growth Bonanza or Bubble?
• 12 June – Guest column : Is Indian Pharma’s spectacular growth Bonanza or Bubble?
• 12 June – BRICS To Fight For Medicine As ‘Human Right’
• 12 June – BRICS To Fight For Medicine As ‘Human Right’
• 12 June – MSF responds to TRIPS exclusion extension for least-developed countries
• 12 June – US Industry beating up India
• 12 June – US Industry beating up India
• 11 June – Indian CL provisions under attack
• 10 June – The EU-India Free Trade Agreement, Corporate Driven Neocolonial Plunder
• 10 June – The EU-India Free Trade Agreement, Corporate Driven Neocolonial Plunder
• 7 June – Obama Trans-Pacific Partnership: Lawmakers Urge President To Address Currency Manipulation
• 7 June – Obama Trans-Pacific Partnership: Lawmakers Urge President To Address Currency Manipulation
• 7 June – South to introduce resolution on access to medicines
• 7 June – South to introduce resolution on access to medicines
• 6 June – Ranbaxy drugs are safe: South African regulator
• 6 June – Ranbaxy drugs are safe: South African regulator
• 5 June – Witnesses at U.S. Trade Hearing Offer Opinions (and Warnings) on Intellectual Property in Upcoming Negotiations with the EU
• 5 June – Witnesses at U.S. Trade Hearing Offer Opinions (and Warnings) on Intellectual Property in Upcoming Negotiations with the EU
• 5 June – Small gap delays India-EU trade treaty: commerce secretary
• 5 June – Small gap delays India-EU trade treaty: commerce secretary
• 4 June – United States: The Curious Case Of Human Gene Patents
• 4 June – United States: The Curious Case Of Human Gene Patents
• 4 June – Compulsory licensing and crown use of patents – report released
• 4 June – Compulsory licensing and crown use of patents – report released
• 4 June – Indian pharma industry produces high quality drugs, says Commerce Min
• 4 June – Indian pharma industry produces high quality drugs, says Commerce Min
• 4 June – Takeover of local pharma companies by foreign firms a concern: Anand Sharma
• 4 June – Takeover of local pharma companies by foreign firms a concern: Anand Sharma
• 4 June – WHO breather for drug-maker Ranbaxy
• 3 June – When the dragon comes calling
• 3 June – Ireland passes legislation for reference pricing of drugs and increased generics use